Drug testing services provide employer-mandated and court-ordered specimen collection, laboratory analysis, and Medical Review Officer services to ensure workforce compliance with federal DOT regulations and state drug-free workplace programs. The industry serves a broad range of end markets including transportation, healthcare, construction, and government, with demand anchored by non-discretionary regulatory requirements. Consolidation is accelerating as national occupational health platforms and background screening companies acquire regional collection networks to offer bundled compliance solutions.
Who sells these: Owner-operators of independent drug testing collection networks, occupational health clinic operators offering drug testing as a core service, and founders of employer compliance programs who built businesses serving transportation, construction, healthcare, and government sectors
3.5–6×
Market multiple range
12–18 months
Avg. exit timeline
$1M–$5M
Typical deal size
SBA Eligible
Broader buyer pool
Focus on these before going to market
Fix these before you go to market
See What Your Drug Testing Services Business Is Worth
Free exit score, valuation range, and action plan — takes 5 minutes.
What Drug Testing Services owners struggle with when trying to exit
8 things to complete before going to market as a Drug Testing Services seller
Not sure where you stand? Get your free exit readiness score in 5 minutes.
Get free scoreTypical acquirer profile for Drug Testing Services businesses
Strategic acquirers such as national occupational health networks, laboratory service companies, or background screening firms seeking to bundle drug testing; alternatively, entrepreneurial first-time buyers with HR, compliance, or healthcare backgrounds using SBA financing
Drug Testing Services businesses typically sell for 3.5–6× EBITDA in the $1M–$5M range. Key value drivers include: Diversified employer client base under multi-year contracts with low churn across industries such as transportation, construction, and healthcare; DOT consortium management and MRO services that create recurring, subscription-like revenue streams; Proprietary collection site network or mobile collection fleet that is difficult for competitors to replicate quickly.
Start by preparing your exit: Compile three years of audited or reviewed financial statements separating collection revenue from pass-through lab charges; Document all client contracts, renewal terms, and historical retention rates by industry segment; Ensure all collector certifications, DOT qualifications, and state occupational health licenses are current and transferable. The typical buyer is: Strategic acquirers such as national occupational health networks, laboratory service companies, or background screening firms seeking to bundle drug testing; alternatively, entrepreneurial first-time buyers with HR, compliance, or healthcare backgrounds using SBA financing
The average exit timeline for a Drug Testing Services business is 12–18 months. This includes preparation, marketing to buyers, due diligence, and closing.
Common value killers for Drug Testing Services businesses include: Heavy revenue concentration in one or two large employer accounts that could churn post-acquisition; Unresolved regulatory compliance issues including expired collector certifications, DOT audit findings, or HIPAA violations; Undocumented or informal client relationships based solely on the owner's personal network with no written contracts; Thin gross margins caused by excessive pass-through lab and MRO costs without value-added service differentiation; Outdated collection procedures, paper chain-of-custody forms, or lack of digital reporting capabilities relative to competitors.
Related Searches
Sell Other Business Types
Get your Drug Testing Services business exit score, valuation range, and a step-by-step action plan — free, in under 5 minutes.
Start Your Free Exit AssessmentFree forever · No broker needed · Takes 5 minutes
For Buyers
For Sellers